Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 135
Filtrar
2.
J Pediatr Health Care ; 15(2): 49-57, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11246192

RESUMEN

Dramatic socioeconomic changes in American family life, along with welfare reform, school readiness initiatives, and research on the relationship between child development and child care, have generated new interest in child care policy. Pediatric nurse practitioners and other pediatric nurses have much to contribute to the formulation of national, state, and local child care policies, especially if they are knowledgeable of key policies and regulatory issues. This article outlines these concepts with an eye toward promoting how pediatric nurses might reclaim their role as catalysts for promoting high-quality child care.


Asunto(s)
Defensa del Niño/legislación & jurisprudencia , Cuidado del Niño/legislación & jurisprudencia , Guarderías Infantiles/legislación & jurisprudencia , Formulación de Políticas , Adolescente , Niño , Preescolar , Humanos , Enfermeras Practicantes , Rol de la Enfermera , Enfermería Pediátrica , Estados Unidos
3.
ANS Adv Nurs Sci ; 23(3): 28-40, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11225048

RESUMEN

Knowledge of health policy is an increasingly important aspect of nursing practice and education, especially as nurses strive to improve the rapidly changing health care delivery system. At the same time, many educators, researchers, foundations, and government officials are touting the benefits of service learning. In particular, service learning offers ways to enhance partnerships between academia and community agencies and to extend learning beyond the traditional classroom. We present a model for educating nurses as advanced practice nurses in health policy that links service learning with a framework for the political development of nurses. Under the rubric of service learning, the curriculum is based on the overlap among health policy, the role of the nurse as consultant, and community-based care. After discussing the importance of health policy for graduate nursing education and reviewing the essentials of service learning, we describe a three-semester graduate sequence in health policy service learning. The focus is on the clinical and classroom components of both individual and group practica and their relationship to stages of nursing's political development. The article concludes with evaluation considerations and the implications of our work for nursing theory, research, practice, and education.


Asunto(s)
Educación de Postgrado en Enfermería , Política de Salud , Liderazgo , Bienestar Social , Connecticut , Curriculum , Evaluación Educacional , Humanos , Modelos Educacionales
4.
J Infect Dis ; 183(3): 409-16, 2001 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-11133372

RESUMEN

Stimulation of peripheral blood mononuclear cells (PBMC) with allogeneic PBMC (ALLO) can result in activity that inhibits the replication of human immunodeficiency virus (HIV). The present study demonstrates that strong anti-HIV activity is dependent on expression of HLA-A*02 by the responding PBMC. Anti-HIV activity was equally effective against 2 primary isolates that use different coreceptors. Neither ALLO-stimulated cell proliferation nor cytokine and beta-chemokine production was associated with the expression of HLA-A*02. ALLO-stimulated production of strong anti-HIV activity required intact PBMC and was not inhibited by monoclonal antibodies directed against nonpolymorphic regions of human leukocyte antigens (HLAs). Anti-HIV activity was generated by ALLO-stimulated CD4(+) cells, CD8(+) T lymphocytes, and monocytes from HLA-A*02-positive patients. These findings provide the first evidence that the production of an HIV inhibitory factor or factors is associated with certain HLA genes and raise new possibilities concerning the role of the major histocompatibility complex in controlling viral infections via alloantigen stimulation.


Asunto(s)
Infecciones por VIH/inmunología , VIH-1/inmunología , Antígenos HLA-A/biosíntesis , Isoantígenos/inmunología , Alelos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Células Cultivadas , Quimiocinas/biosíntesis , Citocinas/biosíntesis , Genes MHC Clase I/genética , Genes MHC Clase I/inmunología , Genes MHC Clase II/genética , Genes MHC Clase II/inmunología , Infecciones por VIH/virología , VIH-1/fisiología , Antígenos HLA-A/genética , Antígenos HLA-A/inmunología , Humanos , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/virología , Activación de Linfocitos , Monocitos/inmunología , Replicación Viral/inmunología
5.
J Exp Med ; 192(10): 1491-500, 2000 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-11085750

RESUMEN

Initial biologic events that underlie sexual transmission of HIV-1 are poorly understood. To model these events, we exposed human immature Langerhans cells (LCs) within epithelial tissue explants to two primary and two laboratory-adapted HIV-1 isolates. We detected HIV-1(Ba-L) infection in single LCs that spontaneously emigrated from explants by flow cytometry (median of infected LCs = 0.52%, range = 0.08-4.77%). HIV-1-infected LCs downregulated surface CD4 and CD83, whereas MHC class II, CD80, and CD86 were unchanged. For all HIV-1 strains tested, emigrated LCs were critical in establishing high levels of infection (0.1-1 microg HIV-1 p24 per milliliter) in cocultured autologous or allogeneic T cells. HIV-1(Ba-L) (an R5 HIV-1 strain) more efficiently infected LC-T cell cocultures when compared with HIV-1(IIIB) (an X4 HIV-1 strain). Interestingly, pretreatment of explants with either aminooxypentane-RANTES (regulated upon activation, normal T cell expressed and secreted) or cellulose acetate phthalate (potential microbicides) blocked HIV-1 infection of LCs and subsequent T cell infection in a dose-dependent manner. In summary, we document HIV-1 infection in single LCs after exposure to virus within epithelial tissue, demonstrate that relatively low numbers of these cells are capable of inducing high levels of infection in cocultured T cells, and provide a useful explant model for testing of agents designed to block sexual transmission of HIV-1.


Asunto(s)
Fármacos Anti-VIH/farmacología , Quimiocina CCL5/análogos & derivados , Células Epiteliales/virología , Infecciones por VIH/transmisión , VIH-1 , Células de Langerhans/virología , Linfocitos T CD4-Positivos/virología , Movimiento Celular , Quimiocina CCL5/farmacología , Técnicas de Cocultivo , Humanos
6.
Nurs Health Care Perspect ; 21(1): 22-8, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11040670

RESUMEN

During the past two decades, the drive to rein in rising health care costs has shifted some of the power in health care policy making from professional groups, government agencies, and not-for-profit health care organizations to large for-profit corporations (1-4). This has been a world-wide phenomenon, as the provision and financing of health care services is shifted from governments to private health care organizations (5,6). In the United States, the shift in power is manifested in profound ways. Market competition and bottom-line economics have permeated the health care system, creating powerful new incentives for mergers, other corporate restructuring, and the shift to for-profit status by formerly not-for-profit insurance companies and providers. Private sector health care is now increasingly influenced by for-profit organizations (3). Moreover, the health insurance industry has been transformed as traditional indemnity insurance is replaced by versions of managed care. The role of government, or the public sector, in setting parameters for health care financing and standards for the delivery of health care services is increasingly outpaced in cost cutting by organizations that directly face the bottom line. In addition, private foundations, many of which are under the auspices of managed care organizations, now fund a large proportion of health care research and demonstration projects, a task once largely within the realm of the government. Through education and experience, nurses have developed political sophistication and understanding of policy making in the public sector (7). The challenge now is to educate nurses to adapt their political and policy strategies to the new health care milieu. This challenge is particularly crucial for advanced practice nurses, who must survive in a managed care environment.


Asunto(s)
Política de Salud/tendencias , Enfermería/tendencias , Sector Privado/tendencias , Educación en Enfermería/tendencias , Humanos , Programas Controlados de Atención en Salud/tendencias , Comercialización de los Servicios de Salud , Privatización/tendencias , Estados Unidos
8.
Blood ; 95(7): 2386-90, 2000 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-10733511

RESUMEN

Disturbances in inflammatory cytokine production and immune regulation coupled with human herpesvirus-8 (HHV-8) infection underlie the current understanding of the pathogenesis of Kaposi's sarcoma (KS), the most common HIV-associated malignancy. The low affinity Fc gamma receptors (FcgammaR) for IgG link humoral and cellular immunity by mediating interaction between antibodies and effector cells, such as phagocytes and natural killer cells. We examined the frequency of polymorphic forms of the low affinity FcgammaRs, FcgammaRIIA, FcgammaRIIIA, and FcgammaRIIIB in 2 cohorts of HIV-infected men with KS and found that the FcgammaRIIIA genotype exerts a significant influence on susceptibility to or protection from KS. The FF genotype was underrepresented in patients with KS, whereas the VF genotype was associated with development of KS. A similar association was observed between FcgammaRIIIA genotypes and HHV-8 seropositivity. These observations suggest a possible role for FcgammaRIIIA in the development of KS during HIV infection.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Genotipo , Receptores de IgG/genética , Sarcoma de Kaposi/genética , Síndrome de Inmunodeficiencia Adquirida/genética , Síndrome de Inmunodeficiencia Adquirida/inmunología , Anticuerpos Antivirales/sangre , Predisposición Genética a la Enfermedad , Herpesvirus Humano 8/inmunología , Humanos , Masculino , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Sarcoma de Kaposi/complicaciones , Sarcoma de Kaposi/inmunología
11.
Proc Natl Acad Sci U S A ; 96(19): 10842-7, 1999 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-10485913

RESUMEN

HIV infection is accompanied by an early immune dysfunction limiting host control of virus and likely contributing to difficulties in achieving a successful vaccine against HIV. We report here that the HIV Tat protein is strongly immunosuppressive, both immediately after immunization of mice with soluble protein (sTat), and in seroconverting humans, and propose that Tat-induced suppression cripples immune surveillance to HIV infection. We show that macrophages are sensitive to sTat stimulation at concentrations 1,000-fold lower (500 pM) than T cells, and this stimulation is accompanied by the immunosuppressive induction of Fas ligand on the macrophage. T cell proliferative defects induced by sTat in vitro can be completely (at lower concentrations of sTat) or partially (at higher concentrations) reversed by antagonists to Fas/Fas ligand interaction. We further report a method to preserve immunogenicity while inactivating Tat immunosuppression through oxidation, which advances the use of oxidized Tat as a component of an anti-HIV vaccine. These observations define additional methods to study the immunosuppressive functions of sTat that now may be rapidly applied to primary isolates from individuals with differing clinical courses. Our findings have immediate relevance for vaccine development, by describing and supporting a strategy that includes inactivated sTat in a multicomponent, anti-HIV vaccine.


Asunto(s)
Productos del Gen tat/farmacología , Tolerancia Inmunológica/fisiología , Vacunas contra el SIDA/metabolismo , Animales , Células Cultivadas , Relación Dosis-Respuesta a Droga , Proteína Ligando Fas , Citometría de Flujo , Productos del Gen tat/inmunología , Productos del Gen tat/metabolismo , Infecciones por VIH/inmunología , Infecciones por VIH/metabolismo , Humanos , Immunoblotting , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/metabolismo , Glicoproteínas de Membrana/antagonistas & inhibidores , Glicoproteínas de Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , Proteínas Recombinantes/farmacología , Linfocitos T Colaboradores-Inductores/efectos de los fármacos , Productos del Gen tat del Virus de la Inmunodeficiencia Humana
12.
Sex Transm Dis ; 26(8): 472-5, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10494939

RESUMEN

PURPOSE: To examine adolescent girls' perception of control over general health and sexually transmitted disease (STD) acquisition. METHODS: Adolescents participating in a longitudinal study were asked questions regarding their perception of their locus of control. These questions, adopted from a previous measure, focused on six loci: internal control, control by parents, partners, peers, and health care providers, and chance. RESULTS: There were 128 girls (mean age, 17 years; range, 14.5 to 18.8); 82% were black and 18% white. Statistically significant associations were found between control of general health and STD acquisition for each locus of control subscale, with the exception of partner control. However, the girls reported significantly less control over STD acquisition than over general health for health care providers, parents, and by chance, and significantly more partner and internal control over STD acquisition than general health. The correlations between parental control over general health and over STD acquisition were inversely correlated with age. Partner control was positively related to current condom use, but internal control was not. CONCLUSIONS: The degree of the locus of control was specific for STD acquisition. Girls who believe they should be able to control STD acquisition may not be using condoms. The view of partners as having control over STD acquisition may represent joint communication or coercion. However, in general these findings support the development of female-controlled methods for STD prevention, such as topical microbicides.


Asunto(s)
Conducta del Adolescente , Actitud Frente a la Salud , Control Interno-Externo , Asunción de Riesgos , Enfermedades de Transmisión Sexual/prevención & control , Enfermedades de Transmisión Sexual/psicología , Adolescente , Femenino , Humanos , Estudios Longitudinales , Encuestas y Cuestionarios
13.
J Immunol ; 163(3): 1666-73, 1999 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-10415073

RESUMEN

Dendritic cells (DC) are the most potent cells involved in the generation of primary and secondary immune responses. To assess the feasibility of using autologous DC as immunotherapy for HIV disease, we analyzed a variety of immune parameters using DC isolated from HIV-infected (HIV+) individuals, as well as DC obtained from HIV-uninfected (HIV-) individuals infected in vitro with HIV. After stimulation with recombinant CD40 ligand (CD40LT), cytokine and beta-chemokine production were similar by DC from HIV- donors infected in vitro with the CCR5-using HIV Ba-L strain (n = 8) compared with uninfected DC from the same donors. Production of beta-chemokines, but not of cytokines, was increased by a CXCR4-using IIIB strain-infected DC (n = 7). Stimulation of HIV-infected DC with CD40LT decreased infection in Ba-L-infected DC, but had no effect on IIIB-infected DC. Consistent with this finding, CD40LT down-regulated CCR5 and up-regulated CXCR4 expression on DC. Monocyte-derived DC were also propagated from 15 HIV+ and 13 HIV- donors. They exhibited similar expression of costimulatory molecules and produced similar amounts of IL-12, IL-10, and beta-chemokines, following stimulation. By contrast, stimulated PBMC from HIV+ patients exhibited decreased IL-12 and increased IL-10 production. In summary, phenotype, cytokine secretion, and beta-chemokine production by DC from HIV+ individuals were normal. These cells may prove useful in boosting cellular immune responses in HIV+ individuals.


Asunto(s)
Traslado Adoptivo , Células Dendríticas/inmunología , Células Dendríticas/virología , Infecciones por VIH/inmunología , VIH-1/inmunología , Monocitos/inmunología , Traslado Adoptivo/métodos , Adulto , Células Cultivadas , Quimiocinas/biosíntesis , Quimiocinas/sangre , Quimiocinas/metabolismo , Citocinas/biosíntesis , Citocinas/sangre , Citocinas/metabolismo , Células Dendríticas/metabolismo , Infecciones por VIH/virología , Seronegatividad para VIH/inmunología , Seropositividad para VIH/inmunología , Seropositividad para VIH/virología , Humanos , Inmunofenotipificación , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/virología , Activación de Linfocitos/inmunología , Linfocitos T/inmunología
15.
J Invest Dermatol ; 111(5): 781-3, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9804338

RESUMEN

Paraneoplastic pemphigus has been associated with both malignancies and multicentric Castleman's disease; the latter is a rare angiolymphoproliferative disorder that has also been linked with human herpesvirus 8 (HHV8) infection. Other diseases definitively associated with HHV8 include Kaposi's sarcoma and primary effusion lymphoma. In a search for additional HHV8-associated diseases, patients with paraneoplastic pemphigus, as well as patients with pemphigus vulgaris and pemphigus foliaceus, were studied. Using an immunofluorescence assay able to specifically detect antibodies directed against lytically induced HHV8 antigens, HHV8 antibodies were not detected in sera from 24 patients with paraneoplastic pemphigus (including 10 with concomitant Castleman's disease) nor from 19 patients with pemphigus vulgaris. Sera from patients with Kaposi's sarcoma and from healthy U.S. blood donors were positive (25 of 26) and negative (none of 20), respectively. In addition, HHV8 DNA was not found in frozen lesional skin of five patients with pemphigus vulgaris and five patients with pemphigus foliaceus by nested polymerase chain reaction (lower limit of detection = 10 copies viral DNA per microg total cellular DNA). Finally, tissue sections of lesional skin from 10 patients with pemphigus vulgaris were negative for HHV8 by in situ hybridization, using probes able to detect both latently and lytically expressed HHV8 genes in Kaposi's sarcoma tissue. In summary, no evidence of HHV8 infection was found in all types of pemphigus using a variety of methods. These findings do not support a general role for HHV8 in skin diseases associated with immunosuppression.


Asunto(s)
Infecciones por Herpesviridae/diagnóstico , Pénfigo/virología , Enfermedad de Castleman/sangre , Enfermedad de Castleman/complicaciones , Infecciones por Herpesviridae/sangre , Infecciones por Herpesviridae/complicaciones , Humanos , Síndromes Paraneoplásicos/sangre , Pénfigo/sangre
16.
Sex Transm Dis ; 25(7): 368-77, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9713918

RESUMEN

BACKGROUND AND OBJECTIVES: For sexually active adolescent girls, sexually transmitted diseases (STDs) represent a significant health problem. Although condom use may be an effective intervention against STDs in this high-risk population, actual use depends on the cooperation of the male partner. Therefore, the development of female-controlled methods such as topical microbicides have been endorsed as an important option for STD prevention. GOALS: This article reviews the current status of intravaginal microbicide development and discusses aspects of adolescent development that should be considered in topical microbicide research. RESULTS: Biological development, cognitive capacities, psychosexual maturation, and the sociocultural context are key features that affect the likelihood that adolescents will adopt microbicides as a specific methods of STD protection. CONCLUSION: Adoption of topical microbicides by adolescents will require an "adolescent friendly" perspective for topical microbicides to have a significant impact on the STD epidemic.


Asunto(s)
Antiinfecciosos/administración & dosificación , Enfermedades de Transmisión Sexual/prevención & control , Administración Tópica , Adolescente , Animales , Antiinfecciosos/uso terapéutico , Femenino , Humanos , Masculino , Psicología del Adolescente
17.
Nurse Pract ; 23(6): 48, 54, 57-60 passim, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9656259

RESUMEN

Decades of practice and research suggest that nurse practitioners (NPs) provide cost-effective and high-quality care. Managed care's emphasis on prevention and cost savings led some policy makers to view NPs as a way to meet the need for primary care providers. However, access to and utilization of NPs has increasingly been controlled by managed care organizations (MCOs) through their selection of providers for primary care panels. This study employed qualitative methodology to examine NPs' experiences with MCOs. Three focus groups, comprising 27 NPs in New York and Connecticut, revealed NPs' mixed reactions to managed care and a range of sentiments regarding NPs' efforts to be listed as primary care providers. The results reflected NPs' concerns about their perceived "invisibility," as well as their sense of "invincibility" in the ways in which NPs are responding to the barriers posed by MCOs. They identified barriers to, as well as ways to facilitate, being listed by MCOs, and described the importance of NPs working individually and collectively in negotiating with MCOs.


Asunto(s)
Grupos Focales , Programas Controlados de Atención en Salud/organización & administración , Enfermeras Practicantes/economía , Connecticut , Recolección de Datos , Humanos , Seguro de Servicios de Enfermería , New York , Ciudad de Nueva York , Enfermeras Practicantes/estadística & datos numéricos , Atención Primaria de Salud , Mecanismo de Reembolso , Encuestas y Cuestionarios
18.
J Nurse Midwifery ; 43(3): 150-61, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9674347

RESUMEN

Managed care poses special challenges to midwives providing reproductive health care. This is owing to the sensitive nature of issues surrounding reproductive health and aspects of managed care that may impede a woman's ability to obtain continuous, confidential, and comprehensive care from the provider of her choice. Variations across payers (ie, Medicare, Medicaid, and commercial insurers) regarding covered benefits and reimbursement of midwifery services also may create obstacles. Furthermore, some physicians and managed care organizations are embracing policies that threaten the ability of midwives to function as primary health care providers for women. Despite these hurdles, midwives have the potential to remain competitive in the new marketplace. This article underscores the importance of being knowledgeable about legislation and policy issues surrounding the financing of midwifery services, quality performance measurement for HMOs as they pertain to reproductive health, and discussions regarding which clinicians should be defined as primary care providers.


PIP: This summary of trends in managed care in the US opens with an overview of the impact of managed care on reproductive health and a review of available data on the use of nurse-midwives and midwives in a managed care setting. Next, state and federal Medicaid laws are summarized, and it is noted that, despite a federal mandate for nurse-midwifery services, states vary in the coverage of such services in Medicaid contracts with managed care plans. This section also considers the factors that have limited the effectiveness of federal legislation to protect the access of Medicaid beneficiaries to timely and confidential family planning (FP) services and to help FP providers not covered by managed care contracts. After a similar look at legislation covering Medicare, the article discusses concerns about quality that have arisen as managed care has reshaped the health care system, especially the quality of reproductive health care. The next sections describe federal legislation covering the length of hospitalization for a mother and newborn, the ways that nurse-midwives are intimately involved in deliberations about managed care and identification of primary care providers, and prospects for the future as various strategies are enacted to enhance reproductive health care in a managed care environment. It is concluded that vigilance and negotiation will be required to ensure that managed care organizations recognize the benefits that nurse-midwives and midwives can provide to patients.


Asunto(s)
Programas Controlados de Atención en Salud/organización & administración , Servicios de Salud Materna/organización & administración , Partería/organización & administración , Adolescente , Adulto , Femenino , Humanos , Reembolso de Seguro de Salud , Tiempo de Internación/legislación & jurisprudencia , Asistencia Médica , Embarazo , Calidad de la Atención de Salud , Estados Unidos
19.
Conn Nurs News ; 71(1): 19-20, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10614235

RESUMEN

Executives in more than 50% of managed care organizations (MCOs) in New York and Connecticut were interviewed for information on the roles, participation, and listing of NPs as primary care providers. MCO executives are highly satisfied with their primary care provider NPs, particularly in women's health and geriatrics, secondary to spending more time teaching and explaining procedures than physicians. Among both health care professionals and the general public there is an overall lack of current knowledge and/or confusion about NPs and their practice. Eighty-two percent of executives in MCOs thought their organization should encourage the use of NPs as primary care providers. Beginning in the early 1960s, advanced practice nursing has shown steady growth. Research has found that NPs provide cost-effective, quality-driven patient care (Brown & Grimes, 1995; Cohen & Juszczak, 1997; Frampton & Wall, 1994; Hardy & Evans, 1995). Many thought health care reform would lead to an expansion of advanced practice nurses (APNs) and other nonphysician providers as primary care providers (Aiken & Salmon, 1994). Funding for and enrollment in graduate nursing programs rose nationwide (American Association of Colleges of Nursing, 1996). Anecdotal reports indicated that NPs were not included in MCO primary care provider panels. The purpose of this study was to explore MCO arrangements with nurse practitioners and the factors that influence them.


Asunto(s)
Empleo/organización & administración , Programas Controlados de Atención en Salud/organización & administración , Enfermeras Practicantes/organización & administración , Connecticut , Humanos , Perfil Laboral , Enfermeras Practicantes/educación , Política Organizacional , Autonomía Profesional , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA